Fergus Fleming
Chief Tech/Sci/R&D Officer chez RENALYTIX PLC
Fortune : 240 999 $ au 31/03/2024
Profil
Fergus Fleming is currently the Director & Chief Technology Officer at Renalytix Plc since 2018 and the Managing Director at Ff Consulting Ltd.
since 2013.
He previously worked as the Head-Business Development at Oncomark Ltd.
from 2016 to 2018.
Mr. Fleming completed his undergraduate degree from the National University of Ireland Galway.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
RENALYTIX PLC
0,57% | 10/04/2024 | 569 481 ( 0,57% ) | 240 999 $ | 31/03/2024 |
Postes actifs de Fergus Fleming
| Sociétés | Poste | Début |
|---|---|---|
| RENALYTIX PLC | Chief Tech/Sci/R&D Officer | 15/03/2018 |
| Ff Consulting Ltd. | Chief Executive Officer | 01/06/2013 |
Anciens postes connus de Fergus Fleming
| Sociétés | Poste | Fin |
|---|---|---|
Oncomark Ltd.
 Oncomark Ltd. Medical SpecialtiesHealth Technology Oncomark Ltd. Engages in the development and application of biomarker panels. The firm’s products include OncoMasTR and pipeline assays. The company was founded by William M. Gallagher and Steve Carl Penney in 2007 and is headquartered in Belfield, Ireland. | Corporate Officer/Principal | 01/10/2018 |
Formation de Fergus Fleming
| National University of Ireland Galway | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RENALYTIX PLC | Technology Services |
| Entreprise privées | 2 |
|---|---|
Oncomark Ltd.
Oncomark Ltd. Medical SpecialtiesHealth Technology Oncomark Ltd. Engages in the development and application of biomarker panels. The firm’s products include OncoMasTR and pipeline assays. The company was founded by William M. Gallagher and Steve Carl Penney in 2007 and is headquartered in Belfield, Ireland. | Health Technology |
| Ff Consulting Ltd. |
